IDXX

IDEXX Laboratories
D

IDXX

Arincen86/100B
704.23
USD
7.22
(1.03%)
Market Open
Last updated: · Delayed 15 min
Fair value719.99Plus-2%498Price 704.231,107
Q4 FY2026 · Earnings report
EPS estimate 3.30Revenue estimate 1.18B
OverviewFinancialsForecastEarningsCompany

IDEXX Laboratories executives and insider trading

Michael Erickson reported no open-market purchases or sales over the last twelve months.

Over the last twelve months IDEXX Laboratories's insiders sold 80,550 shares for 54.14M USD in 45 sales on the open market, and bought 0 shares in 0 purchases.

Insiders over the last twelve months

Insider sales
45
Shares sold
80,550
Value sold
54.14M USD
Insider purchases
0

Insiders buying against selling

Bought on the market
Sold on the market
0
1 week
0
0
1 month
27.40M USD
0
3 months
28.57M USD
0
6 months
28.57M USD
0
1 year
54.14M USD
0
2 years
68.69M USD
Sold, decided at the timeSold under a Rule 10b5-1 plan set in advance

Open-market purchases and sales reported on Form 4, by value. Awards, option exercises and shares withheld for tax are not counted. Whether a sale was under a Rule 10b5-1 plan is read from each Form 4 at the SEC (the box exists on filings since April 2023).

Executives and directors

The people who run the company and the directors who reported trades, with what each bought and sold on the open market over the last twelve months. The CEO first, then whoever traded most.

NamePositionAgeShares sold (12 months)Value sold (12 months)Shares bought (12 months)Last saleShares held after
Jonathan J. Mazelsky Executive Chairman6548,46633.02M USD—4 Nov 2026108,943
George Fennell Executive Vice President—11,3457.34M USD—10 Feb 202612,182
Sharon E. Underberg Executive Vice President, General Counsel, & Corporate Secretary658,9066.13M USD—4 Nov 202616,075
Nimrata Hunt Executive Vice President—4,4512.90M USD—3 Mar 202618,141
Michael J. Lane Executive Vice President and GM Global Reference Laboratories, Diagnostic Solutions & Information Technology583,9792.74M USD—4 Nov 20267,812
Lawrence D Kingsley Director—2,2031.17M USD—4 Sept 202611,771
Daniel M Junius Director—1,200844.89K USD—4 Nov 20262,861

Insider sales and purchases by quarter

How many insider sales and purchases were reported each quarter.

Insider sales Insider purchases

Every insider transaction

Insiders must report every trade in the company's shares to the SEC within two business days, on Form 4. Only purchases and sales are trades on the open market; awards, option exercises, shares withheld for tax and gifts come with pay, and the twelve-month totals leave them out.

DateNameTransactionSharesPriceValueShares held afterFiling
4 Nov 2026Sharon E. UnderbergSale6,348688.254.37M USD9,727Form 4
4 Nov 2026Sharon E. UnderbergSale1,503689.051.04M USD8,224Form 4
4 Nov 2026Sharon E. UnderbergSale1,055690.02727.97K USD7,169Form 4
4 Nov 2026Jonathan J. MazelskySale1,945698.261.36M USD106,998Form 4
4 Nov 2026Jonathan J. MazelskySale4,075699.332.85M USD102,923Form 4
4 Nov 2026Jonathan J. MazelskySale1,667700.331.17M USD101,256Form 4
4 Nov 2026Jonathan J. MazelskySale4,540701.363.18M USD96,716Form 4
4 Nov 2026Jonathan J. MazelskySale2,136702.211.50M USD94,580Form 4
4 Nov 2026Jonathan J. MazelskySale3,950703.452.78M USD90,630Form 4
4 Nov 2026Jonathan J. MazelskySale240705.59169.34K USD90,390Form 4
4 Nov 2026Jonathan J. MazelskySale840707.00593.88K USD89,550Form 4
4 Nov 2026Jonathan J. MazelskySale1,840707.841.30M USD87,710Form 4
4 Nov 2026Jonathan J. MazelskySale1,300709.00921.70K USD86,410Form 4
4 Nov 2026Jonathan J. MazelskySale1,501710.121.07M USD84,909Form 4
4 Nov 2026Jonathan J. MazelskySale775711.31551.26K USD84,134Form 4

Common questions about IDEXX Laboratories's executives and insiders

Source: Financial Modeling Prep